BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting
Reporting app helps facilitate SARS-CoV-2 testing and result reporting from BD Veritor™ Plus System
News provided by
Share this article
Share this article
FRANKLIN LAKES, N.J., March 9, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management, to offer a companion mobile app that enables more streamlined reporting of SARS-CoV-2 antigen testing results performed on the BD Veritor™ Plus System at everyday testing locations, such as schools and businesses. The ImageMover app is available immediately for BD Veritor™ Plus System customers.